Economic Burden of Delayed Diagnosis in Patients with Pulmonary Arterial Hypertension (PAH).

ABSTRACT:

Background

The aim of this study was to assess health care resource utilization (HRU) and costs associated with delayed pulmonary arterial hypertension (PAH) diagnosis in the United States.

Methods

Eligible adults with newly diagnosed PAH from Optum's de-identified Clinformatics^® Data Mart Database (2016-2021) were assigned to mutually exclusive cohorts based on time between first PAH-related symptom and first PAH diagnosis (i.e., ≤12 months' delay, >12 to ≤24 months' delay, >24 months' delay). All-cause HRU and health care costs per patient per month (PPPM) were assessed during the first year following diagnosis and compared across cohorts using regression analysis adjusted for baseline covariates. Sensitivity analyses were conducted to assess outcomes during all

SUBMITTER: DuBrock HM 

PROVIDER: S-EPMC10781905 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature